DK1263444T3 - Use of xanthine derivatives for the manufacture of a medicament intended for the prevention or treatment of osteoporosis - Google Patents

Use of xanthine derivatives for the manufacture of a medicament intended for the prevention or treatment of osteoporosis

Info

Publication number
DK1263444T3
DK1263444T3 DK01907785T DK01907785T DK1263444T3 DK 1263444 T3 DK1263444 T3 DK 1263444T3 DK 01907785 T DK01907785 T DK 01907785T DK 01907785 T DK01907785 T DK 01907785T DK 1263444 T3 DK1263444 T3 DK 1263444T3
Authority
DK
Denmark
Prior art keywords
osteoporosis
prevention
manufacture
treatment
medicament intended
Prior art date
Application number
DK01907785T
Other languages
Danish (da)
Inventor
Yamina Bouali
Yusuke Satoh
Jean-Paul Vevert
Guenter Johannes Billen
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1263444T3 publication Critical patent/DK1263444T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH

Abstract

. The invention concerns the use of a xanthine derivative of formula (I) and its physiologically acceptable salts for preparing a medicine for preventing or treating osteoporosis, wherein: R1, R2 and R3 are as defined in the description.
DK01907785T 2000-02-15 2001-02-14 Use of xanthine derivatives for the manufacture of a medicament intended for the prevention or treatment of osteoporosis DK1263444T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0001846A FR2804867B1 (en) 2000-02-15 2000-02-15 APPLICATION OF XANTHINE DERIVATIVES FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OR TREATMENT OF OSTEOPOROSIS

Publications (1)

Publication Number Publication Date
DK1263444T3 true DK1263444T3 (en) 2005-11-14

Family

ID=8847005

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01907785T DK1263444T3 (en) 2000-02-15 2001-02-14 Use of xanthine derivatives for the manufacture of a medicament intended for the prevention or treatment of osteoporosis

Country Status (9)

Country Link
EP (1) EP1263444B1 (en)
AT (1) ATE300304T1 (en)
AU (1) AU2001235669A1 (en)
DE (1) DE60112253T2 (en)
DK (1) DK1263444T3 (en)
ES (1) ES2242731T3 (en)
FR (1) FR2804867B1 (en)
PT (1) PT1263444E (en)
WO (1) WO2001060372A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332634T2 (en) * 1992-03-04 2003-05-08 Cell Therapeutics Inc ENANTIOMIC HYDROXYLATED XANTHINE COMPOUNDS
DE19540798A1 (en) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as medicines
JPH09169665A (en) * 1995-12-21 1997-06-30 Kenichi Miyamoto Agent for treatment osteoporosis
ATE226583T1 (en) * 1996-06-07 2002-11-15 Hoechst Ag USE OF THEOPHYLLINE DERIVATIVES FOR THE TREATMENT AND PROPYLAXIS OF SHOCK CONDITIONS, NEW XANTHINE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
JPH1192379A (en) * 1997-07-24 1999-04-06 Kunio Takaoka Preventive or therapeutic agent for osteopathy

Also Published As

Publication number Publication date
ATE300304T1 (en) 2005-08-15
AU2001235669A1 (en) 2001-08-27
FR2804867A1 (en) 2001-08-17
DE60112253T2 (en) 2006-06-01
FR2804867B1 (en) 2002-09-20
EP1263444A2 (en) 2002-12-11
ES2242731T3 (en) 2005-11-16
DE60112253D1 (en) 2005-09-01
EP1263444B1 (en) 2005-07-27
PT1263444E (en) 2005-10-31
WO2001060372A2 (en) 2001-08-23
WO2001060372A3 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
NO20021328L (en) Pyrazolopyrimidia as therapeutic agents
NO20052927L (en) 2,4,6-Trisubstituted Pyrimidines of Phosphotidylinositol (PI) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer
DE50311898D1 (en) FREDERICAMYCIN DERIVATIVES AS A MEDICAMENT FOR TUMOR TREATMENT
SE9904505D0 (en) Novel compounds
MXPA04001500A (en) Compounds effecting glucokinase.
BR0208678A (en) Compound, pharmaceutical composition, use of a compound
UA74346C2 (en) Aminodicarboxylic acids derivatives, use thereof and a medicament
NO20053748L (en) Pyrrolopyridazine derivatives.
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
HUP0202570A1 (en) Compositions and therapeutic methods involving isoflavones and analogues thereof
BR0315580A (en) Methylene Urea Derivatives
ATE372995T1 (en) BENZO(B)(1,4)DIOXEPINE DERIVATIVES
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
MXPA05005790A (en) Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders.
NO20023486D0 (en) Pyrrole-type compounds, compounds containing compounds and their use in the treatment of cancer and viral diseases
DE60026491D1 (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
DE60123117D1 (en) USE OF ALPHA-HALOGENACRYLOYL-DISTAMYCIN DERIVATIVES FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CANCER
MXPA02004441A (en) Isoxazole derivatives to be used as phosphodiesterase vii inhibitors.
NO20053876D0 (en) Carbonylamino-substituted acylphenylurea derivatives, process for their preparation and use thereof
NO20030061L (en) Tyrosine derivatives as phosphatase inhibitors
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
DK1263444T3 (en) Use of xanthine derivatives for the manufacture of a medicament intended for the prevention or treatment of osteoporosis
PE20030236A1 (en) DERIVATIVES OF BENZIMIDAZOLE 1-ARIL-2-N, S- OR O-SUBSTITUTES, OBTAINING DRUGS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES
NO20021337D0 (en) 4-Benzylaminoquinoline Conjugates with Bile Acid and Their Heteroanalogs, Procedures for their Preparation, Drugs Containing These Compounds and Their Use
TW200505913A (en) Novel oxazole derivatives, their manufacture and use as pharmaceutical agents